Orthopaedic and Traumatology Department, Cochin Hospital, Paris Cité University, 27, rue du Faubourg-Saint-Jacques, Paris, 75014, France.
Inserm U1153, Paris Cité University, 1 Parvis Notre-Dame - Pl. Jean-Paul II, Paris, 75004, France.
World J Surg Oncol. 2024 Sep 4;22(1):233. doi: 10.1186/s12957-024-03478-3.
Primary malignant bone tumor of the pelvis is an uncommon lesion, the resection of which via freehand osteotomy is subject to inaccuracy due to its three-dimensional anatomy. Patient-Specific Guides (PSG), also called Patient-Specific Instruments (PSI) are essential to ensure surgical planning and resection adequacy. Our aim was to assess their use and effectiveness.
A monocentric retrospective study was conducted on 42 adult patients who underwent PSG-based resection of a primary malignant bone tumor of the pelvis. The primary outcome was the proportion of R0 bone margins. The secondary outcomes were the proportion of overall R0 margins, considering soft-tissue resection, the cumulative incidence of local recurrence, and the time of production for the guides. A comparison to a previous series at our institution was performed regarding histological margins.
Using PSGs, 100% R0 safe bone margin was achieved, and 88% overall R0 margin due to soft-tissue resection being contaminated, while the comparison to the previous series showed only 80% of R0 safe bone margin. The cumulative incidences of local recurrence were 10% (95% CI: 4-20%) at one year, 15% (95% CI: 6-27%) at two years, and 19% (95% CI: 8-33%) at five years. The median overall duration of the fabrication process of the guide was 35 days (Q1-Q3: 26-47) from the first contact to the surgery date.
Patient-Specific Guides can provide a reproducible safe bony margin.
骨盆原发性恶性骨肿瘤较为少见,由于其三维解剖结构,徒手截骨切除往往不够精确。患者特异性导向器(PSG),也称为患者特异性器械(PSI),对于确保手术规划和切除充分性至关重要。我们旨在评估其使用情况和效果。
对 42 例成人骨盆原发性恶性骨肿瘤行 PSG 辅助切除的患者进行单中心回顾性研究。主要结局是 R0 骨切缘的比例。次要结局是考虑软组织切除后的整体 R0 切缘比例、局部复发的累积发生率和导向器的制作时间。对组织学切缘与我院既往的系列研究进行了比较。
使用 PSG 可实现 100%的 R0 安全骨切缘,由于软组织切除污染,88%达到整体 R0 切缘,而与既往系列研究的比较仅显示 80%的 R0 安全骨切缘。1 年、2 年和 5 年的局部复发累积发生率分别为 10%(95%CI:4-20%)、15%(95%CI:6-27%)和 19%(95%CI:8-33%)。导向器制作过程的总中位时间为从首次接触到手术日期的 35 天(Q1-Q3:26-47)。
患者特异性导向器可以提供可重复的安全骨切缘。